蛋白质工程和发展

As biologics gain greater prominence, protein engineers are adapting to new indications, new advances in targeting science, new product formats, and products that are truly differentiated in the marketplace. The Protein Engineering & Development pipeline offers a weeklong exploration of state-of-the-art approaches for developing safe and effective protein and antibody-based therapeutics, including improving product qualities, optimizing lead and candidate selection, and the application of deep sequencing and single cell analysis.


1月20~21日

Recombinant Protein Therapeutics
( 重组蛋白质疗法 )

1月21~22日

Lead and Candidate Selection for Therapeutic Proteins
( 治疗用蛋白质的先导化合物和药剂候补选择 )

1月23~24日

Deep Sequencing and Single Cell Analysis for Antibody Discovery
( 抗体发现的深度定序和单一细胞解析 )


Keynote Speakers

Aris N. Economides, PhD, Vice President, Research, Regeneron Pharmaceuticals, Inc.


Peter M. Tessier, PhD, Professor, Pharmaceutical Sciences, Chemical Engineering and Biomedical Engineering, University of Michigan


Bryan Briney, PhD, Assistant Professor, Immunology and Microbiology, The Scripps Research Institute


* 活动内容有可能不事先告知作更动及调整。

Choose your language
Chinese
Japanese
Korean
English






2020年会议节目和培训研讨会


免费电子邮件通知服务